Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.

Khasraw, Mustafa; Mukaro, Violet Rudo; West, Linda; White, Karen; Rippy, Elisabeth; Brandt, Conrad; Tobler, Robert; Murphy, Caitlin Clare; Collins, Ian; Baron-Hay, Sally E; Ashley, David M; Patil, Sujata

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.

conference contribution

posted on 2024-06-03, 22:17 authored by Mustafa Khasraw, Violet Rudo Mukaro, Linda West, Karen White, Elisabeth Rippy, Conrad Brandt, Robert Tobler, Caitlin Clare Murphy, Ian CollinsIan Collins, Sally E Baron-Hay, David M Ashley, Sujata Patil

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1200/JCO.2016.34.15_suppl.e12515

Location

Chicago, IL

Language

English

Author URL

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000404665401241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a045e4b2bb1f2b747c68c720ec8913b7

Publication classification

E3.1 Extract of paper

Volume

34

Start date

2016-06-03

End date

2016-06-07

ISSN

0732-183X

eISSN

1527-7755

Title of proceedings

JOURNAL OF CLINICAL ONCOLOGY

Event

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Issue

15

Publisher

AMER SOC CLINICAL ONCOLOGY

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Oncology 3202 Clinical sciences 3211 Oncology and carcinogenesis

Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.

History

Related Materials

Location

Language

Author URL

Publication classification

Volume

Start date

End date

ISSN

eISSN

Title of proceedings

Event

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports